Toi M - Search Results

1

Comparison of different definitions of pathologic complete response in operable breast cancer: a pooled analysis of three prospective neoadjuvant studies of JBCRG.

Kuroi K, Toi M, Ohno S, Nakamura S, Iwata H, Masuda N, Sato N, Tsuda H, Kurosumi M, Akiyama F. Kuroi K, et al. Among authors: toi m. Breast Cancer. 2015 Nov;22(6):586-95. doi: 10.1007/s12282-014-0524-4. Epub 2014 Feb 27. Breast Cancer. 2015. PMID: 24574277 Free PMC article.

2

Prognostic significance of co-expression of c-erbB-2 oncoprotein and epidermal growth factor receptor in breast cancer patients.

Osaki A, Toi M, Yamada H, Kawami H, Kuroi K, Toge T. Osaki A, et al. Among authors: toi m. Am J Surg. 1992 Oct;164(4):323-6. doi: 10.1016/s0002-9610(05)80897-9. Am J Surg. 1992. PMID: 1357997

3

[Prognostic significance of expression of c-ERBB-2 oncoprotein in breast cancer patients].

Osaki A, Toi M, Yamada H, Kawami H, Kuroi K, Toge T. Osaki A, et al. Among authors: toi m. Gan To Kagaku Ryoho. 1991 Jun;18(7):1181-5. Gan To Kagaku Ryoho. 1991. PMID: 1675844 Japanese.

4

Tumor angiogenesis is an independent prognostic indicator in primary breast carcinoma.

Toi M, Kashitani J, Tominaga T. Toi M, et al. Int J Cancer. 1993 Sep 30;55(3):371-4. doi: 10.1002/ijc.2910550305. Int J Cancer. 1993. PMID: 7690738

5

Role of epidermal growth factor receptor expression in primary breast cancer: results of a biochemical study and an immunocytochemical study.

Toi M, Tominaga T, Osaki A, Toge T. Toi M, et al. Breast Cancer Res Treat. 1994 Jan;29(1):51-8. doi: 10.1007/BF00666181. Breast Cancer Res Treat. 1994. PMID: 7912567 Clinical Trial.

6

Primary squamous cell carcinoma of the breast after cured Hodgkin's disease.

Kuroi K, Osaki A, Yamada H, Toi M, Toge T, Takimoto Y, Kuramoto A, Arihiro K, Inai K. Kuroi K, et al. Among authors: toi m. Surg Today. 1993;23(1):81-4. doi: 10.1007/BF00309006. Surg Today. 1993. PMID: 8461611

7

Tumor angiogenesis in breast cancer: its importance as a prognostic indicator and the association with vascular endothelial growth factor expression.

Toi M, Inada K, Suzuki H, Tominaga T. Toi M, et al. Breast Cancer Res Treat. 1995;36(2):193-204. doi: 10.1007/BF00666040. Breast Cancer Res Treat. 1995. PMID: 8534867

8

Quantitative analysis of vascular endothelial growth factor in primary breast cancer.

Toi M, Kondo S, Suzuki H, Yamamoto Y, Inada K, Imazawa T, Taniguchi T, Tominaga T. Toi M, et al. Cancer. 1996 Mar 15;77(6):1101-6. doi: 10.1002/(sici)1097-0142(19960315)77:6<1101::aid-cncr15>3.0.co;2-5. Cancer. 1996. PMID: 8635130

9

[Docetaxel as a single agent in cases of advanced/recurrent breast cancer previously treated with anthracycline].

Nagai S, Toi M, Kuroi K, Hayashi K, Tominaga T. Nagai S, et al. Among authors: toi m. Gan To Kagaku Ryoho. 1999 Nov;26(13):2037-42. Gan To Kagaku Ryoho. 1999. PMID: 10584568 Clinical Trial. Japanese.

10

Tissue factor expression in breast cancer tissues: its correlation with prognosis and plasma concentration.

Ueno T, Toi M, Koike M, Nakamura S, Tominaga T. Ueno T, et al. Among authors: toi m. Br J Cancer. 2000 Jul;83(2):164-70. doi: 10.1054/bjoc.2000.1272. Br J Cancer. 2000. PMID: 10901365 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

786 results

Search Page

Filters